BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27975300)

  • 1. Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.
    Abdel-Daim MM; El-Sayed YS; Eldaim MA; Ibrahim A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):301-309. PubMed ID: 27975300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity.
    Abdel-Daim MM; Aleya L; El-Bialy BE; Abushouk AI; Alkahtani S; Alarifi S; Alkahtane AA; AlBasher G; Ali D; Almeer RS; Al-Sultan NK; Alghamdi J; Alahmari A; Bungau SG
    Environ Sci Pollut Res Int; 2019 May; 26(15):15248-15254. PubMed ID: 30929167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats.
    Ibrahim A; Eldaim MA; Abdel-Daim MM
    Cytotechnology; 2016 Aug; 68(4):1039-48. PubMed ID: 25720368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.
    Elsherbiny NM; Eladl MA; Al-Gayyar MM
    Cytokine; 2016 Jan; 77():26-34. PubMed ID: 26517155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats.
    Nematbakhsh M; Ashrafi F; Safari T; Talebi A; Nasri H; Mortazavi M; Khazaei M; Baradaran-Mahdavi MM
    J Nephrol; 2012; 25(3):410-7. PubMed ID: 21928232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic protective effects of ceftriaxone and ascorbic acid against subacute deltamethrin-induced nephrotoxicity in rats.
    Abdel-Daim MM; El-Ghoneimy A
    Ren Fail; 2015 Mar; 37(2):297-304. PubMed ID: 25691087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
    Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
    Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
    J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Molsidomine Against Cisplatin-Induced Nephrotoxicity.
    Karakoc HT; Altintas R; Parlakpinar H; Polat A; Samdanci E; Sagir M; Duran ZR
    Adv Clin Exp Med; 2015; 24(4):585-93. PubMed ID: 26469102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of bone morphogenetic protein (BMP)-6 and osteopontin in cisplatin (CDDP)-induced rat renal fibrosis.
    Yano R; Golbar HM; Izawa T; Sawamoto O; Kuwamura M; Yamate J
    Exp Toxicol Pathol; 2015 Feb; 67(2):99-107. PubMed ID: 25467747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
    González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
    Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological effects of a vitamin K
    Uchida M; Miyoshi T; Miyamoto Y
    J Vet Med Sci; 2017 Sep; 79(9):1507-1515. PubMed ID: 28717059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lipopolysaccharide on the appearance of macrophage populations and fibrogenesis in cisplatin-induced rat renal injury.
    Yamate J; Machida Y; Ide M; Kuwamura M; Sawamoto O; LaMarre J
    Exp Toxicol Pathol; 2004 Oct; 56(1-2):13-24. PubMed ID: 15581271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
    Korolczuk A; Maciejewski M; Smolen A; Dudka J; Czechowska G; Widelska I
    J Physiol Pharmacol; 2014 Dec; 65(6):867-76. PubMed ID: 25554991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
    Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
    Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.
    Wang HY; Wang YJ; Cui MJ; Gu CM; Yang LZ; Zhao Y; Chen Y; Zhao D; Li TS; Chi BR
    Indian J Biochem Biophys; 2011 Oct; 48(5):308-15. PubMed ID: 22165288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of CV247 against cisplatin nephrotoxicity in rats.
    Máthé C; Szénási G; Sebestény A; Blázovics A; Szentmihályi K; Hamar P; Albert M
    Hum Exp Toxicol; 2014 Aug; 33(8):789-99. PubMed ID: 23653282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats.
    Ashrafi F; Nematbakhsh M; Safari T; Talebi A; Nasri H; Khazaei M; Baradaran-Mahdavi MM; Jafapisheh A; Olia B; Pirhaji O; Hashemi-Nia SJ; Eshraghi F; Pezeshki Z; Mortazavi M
    Iran J Kidney Dis; 2012 Sep; 6(5):361-5. PubMed ID: 22976262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.